KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Depreciation & Amortization (CF) (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Depreciation & Amortization (CF) readings, the most recent being $13.7 million for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 12.71% to $13.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $59.0 million, a 6.4% decrease, with the full-year FY2025 number at $59.0 million, down 6.39% from a year prior.
  • Depreciation & Amortization (CF) hit $13.7 million in Q4 2025 for Ginkgo Bioworks Holdings, down from $14.2 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $21.1 million in Q3 2023 to a low of $5.6 million in Q1 2021.
  • Median Depreciation & Amortization (CF) over the past 5 years was $13.9 million (2025), compared with a mean of $13.2 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): skyrocketed 136.18% in 2023 and later plummeted 32.12% in 2024.
  • Ginkgo Bioworks Holdings' Depreciation & Amortization (CF) stood at $8.0 million in 2021, then surged by 95.76% to $15.7 million in 2022, then dropped by 18.06% to $12.8 million in 2023, then increased by 21.93% to $15.7 million in 2024, then fell by 12.71% to $13.7 million in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $13.7 million (Q4 2025), $14.2 million (Q3 2025), and $15.8 million (Q2 2025) per Business Quant data.